Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H31NO2 |
| Molecular Weight | 329.4763 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C=C(C(=O)CC(C)(C)C(C)(C)O)C2=C1C=CC=C2
InChI
InChIKey=GWHGUYKAGQLPTQ-UHFFFAOYSA-N
InChI=1S/C21H31NO2/c1-6-7-10-13-22-15-17(16-11-8-9-12-18(16)22)19(23)14-20(2,3)21(4,5)24/h8-9,11-12,15,24H,6-7,10,13-14H2,1-5H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-4-HTMPIPO
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4-HTMPIPO
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
PRIMARY | 4-HTMPIPO is a synthetic cannabinoid drug first identified in smoking products purchased from online vendors in 2012. 4-HTMPIPO is the product resulting from the electrophilic addition of water to the cyclopropane moiety of synthetic cannabinoid UR-144. Nothing is known about the in vitro or in vivo pharmacology of 4-HTMPIPO. | ||
|
4NL5X39H8F
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
PRIMARY | |||
|
DTXSID901045446
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
PRIMARY | |||
|
1445751-38-1
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
PRIMARY | |||
|
72720476
Created by
admin on Sat Dec 16 10:25:36 GMT 2023 , Edited by admin on Sat Dec 16 10:25:36 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
